Michelle T. Long, MD
Assistant Professor
Boston Medical Center
Dept of Medicine
Gastroenterology

MD, Tufts University School of Medicine




I am an early career physician scientist primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with non-alcoholic fatty liver disease (NAFLD). My clinical and research interests center on the relationship between NAFLD and cardiovascular disease. My research is primarily based at the Framingham Heart Study where I am the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. I am investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. I have expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. I am also a clinical gastroenterologist and endoscopist.

I am additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and run the clinical trials for the BMC Fatty Liver Clinic.

My other research interests include alcoholic liver disease, hepatitis C, outcomes in end-stage liver disease/cirrhosis.

2016 Boston University School of Medicine: Women's Leadership Conference Selected Participant
2016 Boston University School of Medicine: Faculty Development and Diversity Grant Recipient
2015-2019 Boston University School of Medicine: NIH Loan Repayment Program Recipient
2014 Boston University School of Medicine: 3rd Place, Evans Research Day
2009 Tufts University School of Medicine: Massachusetts Medical Society Scholars Award
2009 Tufts University School of Medicine: Phi Delta Epsilon Fraternity Award
2009 Tufts University School of Medicine: Glasgow-Rubin Citation for Academic Achievement
2009 Tufts University School of Medicine: Alpha Omega Alpha
2008 Tufts University School of Medicine: Ada Draper, MD Scholarship
2008 Tufts University School of Medicine: Magna cum laude Scientific electronic exhibit award
2006-2007 Tufts University School of Medicine: Boston Albert Schweitzer Fellowship
2006-2008 Tufts University School of Medicine: USA Funds Scholarship
2004 Middlebury College: Magna cum laude


Prevalence and risk factors for hepatic steatosis and fibrosis as measured by transient elastography
03/15/2016 - 05/31/2019 (PI)
Echosens



Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the…
01/12/2018 - 11/30/2022 (PI)
NIH-NIDDK
1K23DK113252-01A1

MB130-068
12/06/2018 - 12/06/2021 (PI)
Bristol-Myers

Determining the burden, heritability, and clinical implications of increased liver stiffness from…
01/02/2019 - 01/01/2021 (PI)
Gilead Sciences

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating …
05/16/2017 - 05/16/2020 (PI)
Intercept Pharmaceuticals, Inc.

A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients with moderately severe A…
10/06/2016 - 10/05/2018 (PI)
Indiana University NIH-NIAAA
4U01AA021840-05


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Wilechansky RM, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: a secondary analysis. Liver Int. 2019 Apr 29.View Related Profiles. PMID: 31033142.
     
  2. Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 Apr 03.View Related Profiles. PMID: 30945037.
     
  3. Brunner KT, Henneberg CJ, Wilechansky RM, Long MT. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Curr Obes Rep. 2019 Apr 03. PMID: 30945129.
     
  4. Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Therap Adv Gastroenterol. 2019; 12:1756284819832237.View Related Profiles. PMID: 30984290.
     
  5. Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds LM, Ghanbari M, Muka T, van Meurs JBJ, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SLR, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Darwish Murad S, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. Diabetes. 2019 May; 68(5):1073-1083. PMID: 30936141.
     
  6. Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One. 2019; 14(3):e0211811.View Related Profiles. PMID: 30840670.
     
  7. Hennein R, Liu C, McKeown NM, Hoffmann U, Long MT, Levy D, Ma J. Increased Diet Quality is Associated with Long-Term Reduction of Abdominal and Pericardial Fat. Obesity (Silver Spring). 2019 Apr; 27(4):670-677. PMID: 30825267.
     
  8. Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds L, Ghanbari M, Muka T, van Meurs J, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SL, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Murad SD, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver Disease. Diabetes. 2019 Feb 22. PMID: 30796027.
     
  9. Simon TG, Deng X, Liu CT, Chung RT, Long MT. The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study. Liver Int. 2018 Dec 29.View Related Profiles. PMID: 30597691.
     
  10. Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. Clin Gastroenterol Hepatol. 2019 May; 17(6):1157-1164.e4.View Related Profiles. PMID: 30476583.
     
Showing 10 of 37 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 37 publications over 6 distinct years, with a maximum of 9 publications in 2018

YearPublications
20071
20155
20166
20178
20189
20198

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Education Mentor
  • Project Mentor
  • Research / Scholarly Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

818 Harrison Ave
Boston MA 02118
Google Map


Long's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department